Gregory David Gubitz

All filings by Gregory David Gubitz on record concern HLS Therapeutics Inc. In total, 5 filings cover trades dated from 19 August 2019 to 25 August 2022.

In open-market terms, that means 1 purchase worth €30k on one side and 4 sales worth €3.9M on the other. On balance, insiders were net sellers of €3.8M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2022, the count stands at no purchases and 1 sale.

The record was last updated on 26 August 2022 with an open-market sale (€1.6M) in HLS Therapeutics Inc. The last purchase on record was published on 20 August 2019, which is 2,625 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 3 days. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.